dRx Capital Novartis Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
43
- Portfolio
-
13
- Exits
-
14
dRx Capital Novartis General Information
Company Description
Founded in 2015, dRx Capital Novartis is a venture capital firm based in Basel, Switzerland. The firm prefers to invest in healthcare, artificial intelligence and machine learning, big data, research and development optimization, patient care, and the pharma supply chain and commercialization sectors.
Business Details
Website
www.drxcapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Novartis Campus
- 4056 Basel
- Switzerland
dRx Capital Novartis Investments (43)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Yseop | 05-Dec-2023 | PE Growth/Expansion | Business/Productivity Software | Generating Revenue | ||
| Octave Bioscience | 26-Jul-2023 | Laboratory Services (Healthcare) | Generating Revenue | |||
| RxLightning | 24-May-2023 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Holmusk | 06-Jan-2023 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| H1 Insights | 09-Jun-2022 | Other Healthcare Services | Generating Revenue | |||
| Peptone | 09-Jun-2022 | Discovery Tools (Healthcare) | Pre-Clinical Trials | |||
| Koneksa | 07-Feb-2022 | Other Healthcare Technology Systems | Clinical Trials - General | |||
| NuvoAir Medical | 19-Jan-2022 | Clinics/Outpatient Services | Generating Revenue | |||
| Pear Therapeutics | 03-Dec-2021 | PIPE | Other Healthcare Technology Systems | Out of Business | ||
| Cala Health | 16-Nov-2021 | Later Stage VC | Therapeutic Devices | Generating Revenue |
dRx Capital Novartis Exits (14)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Freenome | 20-Jul-2026 | Reverse Merger | |
| YourBio Health | 01-Jan-2026 | ||
| Aktana | 31-Oct-2025 | ||
| Xealth | 08-Jul-2025 | ||
| Omada | 06-Jun-2025 | ||
| RxLightning | 01-Jun-2025 | ||
| Science 37 Holdings | 11-Mar-2024 | ||
| Tact.ai | 01-Nov-2023 | ||
| Aspen RxHealth | 01-Jan-2023 | Merger/Acquisition | |
| Pear Therapeutics | 03-Dec-2021 | Reverse Merger |
dRx Capital Novartis Investments by Industry, Year, and Region
dRx Capital Novartis Co-Investors (53)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Novartis | 3 |
|
|
||
| Hikma Ventures |
|
|
|||
| MSD Global Health Innovation Fund |
|
|
|||
| McKesson Ventures |
|
|
|||
| Bessemer Venture Partners |
|
|
dRx Capital Novartis FAQs
-
What is dRx Capital Novartis?
Founded in 2015, dRx Capital Novartis is a venture capital firm based in Basel, Switzerland.
-
When was dRx Capital Novartis founded?
dRx Capital Novartis was founded in 2015.
-
Where is dRx Capital Novartis headquartered?
dRx Capital Novartis is headquartered in Basel, Switzerland.
-
What is dRx Capital Novartis's total asset value?
dRx Capital Novartis has around in total assets under management.
-
How many investments has dRx Capital Novartis made?
dRx Capital Novartis has made 43 investments.
-
What has dRx Capital Novartis invested in?
dRx Capital Novartis has made numerous investments in companies like Yseop, Octave Bioscience, and RxLightning within the Business/Productivity Software, Laboratory Services (Healthcare), and Enterprise Systems (Healthcare) industries.
-
What has dRx Capital Novartis invested in recently?
dRx Capital Novartis's latest investment was on 05-Dec-2023 in Yseop, a company within the Business/Productivity Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process